The healthcare utilisation and cost of prolonged-release fampridine without disease-modifying therapies in patients with multiple sclerosis throughout Germany during 2011-2013

EUROPEAN JOURNAL OF NEUROLOGY(2016)

引用 0|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要